Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism - PubMed (original) (raw)
. 2003 Oct;26(10):829-37.
doi: 10.1291/hypres.26.829.
Affiliations
- PMID: 14621187
- DOI: 10.1291/hypres.26.829
Free article
Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism
Motoyuki Iemitsu et al. Hypertens Res. 2003 Oct.
Free article
Abstract
Hypertension-induced pathological cardiac hypertrophy (hypertensive heart) and exercise training-induced physiological cardiac hypertrophy (athletic heart) have differences in cardiac properties. We hypothesized that gene expression of energy metabolic enzymes differs between these two types of cardiac hypertrophy. To investigate whether mRNA expression of key enzymes in the long-chain fatty acid (FA), glucose, and lactic acid metabolic pathways differs between these two types of cardiac hypertrophy, we used the hearts of spontaneously hypertensive rats (SHR; 19 weeks old) as a model of the hypertensive heart, swim-trained rats (Trained; 19 weeks old, swimming training for 15 weeks) as a model of the athletic heart, and sedentary Wistar-Kyoto rats (Control; 19 weeks old). SHR developed hypertensive cardiac hypertrophy, of which cardiac function was deteriorated, whereas Trained rats developed an athletic heart, of which cardiac function was enhanced. The mRNA expression of CD36, which involved in uptake of long-chain FA, in the heart was almost never detected in the SHR group. Furthermore, the mRNA expression of key enzymes in the long-chain FA metabolic pathway (acyl CoA synthase [ACoAS], carnitine palmitoyl transferase [CPT]-I, CPT-II, and isocitrate dehydrogenase [ISCD]) in the heart was significantly higher in the SHR group compared with the Control group. The mRNA expression of ACoAS, CPT-I, ISCD, and CD36 in the heart did not differ between Trained group and Control group, whereas that of CPT-II in the Trained group was significantly higher compared with the Control group. The mRNA expression of key enzymes (phosphofructokinase and lactate dehydrogenase) in glycolytic metabolic pathway in the heart was markedly higher in the SHR group compared with the Control group, whereas these mRNA expressions did not differ between Trained group and Control group. These findings suggest that the molecular phenotypes in the energy metabolic system differ in hypertension-induced pathological and exercise training-induced physiological cardiac hypertrophy, and these differences may participate in the differences in cardiac function.
Similar articles
- Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat.
Iemitsu M, Miyauchi T, Maeda S, Sakai S, Kobayashi T, Fujii N, Miyazaki H, Matsuda M, Yamaguchi I. Iemitsu M, et al. Am J Physiol Regul Integr Comp Physiol. 2001 Dec;281(6):R2029-36. doi: 10.1152/ajpregu.2001.281.6.R2029. Am J Physiol Regul Integr Comp Physiol. 2001. PMID: 11705790 - The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.
Iemitsu M, Shimojo N, Maeda S, Irukayama-Tomobe Y, Sakai S, Ohkubo T, Tanaka Y, Miyauchi T. Iemitsu M, et al. Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H136-44. doi: 10.1152/ajpheart.01417.2006. Epub 2008 May 2. Am J Physiol Heart Circ Physiol. 2008. PMID: 18456726 - Effects of medium-chain triglyceride (MCT) application to SHR on cardiac function, hypertrophy and expression of endothelin-1 mRNA and other genes.
Shimojo N, Miyauchi T, Iemitsu M, Irukayama-Tomobe Y, Maeda S, Ohkubo T, Tanaka Y, Goto K, Yamaguchi I. Shimojo N, et al. J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S181-5. doi: 10.1097/01.fjc.0000166263.19852.fc. J Cardiovasc Pharmacol. 2004. PMID: 15838274 - Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies.
Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Bernardo BC, et al. Pharmacol Ther. 2010 Oct;128(1):191-227. doi: 10.1016/j.pharmthera.2010.04.005. Epub 2010 May 12. Pharmacol Ther. 2010. PMID: 20438756 Review. - Beneficial Effects of Exercise on Hypertension-Induced Cardiac Hypertrophy in Adolescents and Young Adults.
Tsuda T, Robinson BW. Tsuda T, et al. Curr Hypertens Rep. 2024 Nov;26(11):451-462. doi: 10.1007/s11906-024-01313-4. Epub 2024 Jun 18. Curr Hypertens Rep. 2024. PMID: 38888690 Review.
Cited by
- Longitudinal Evaluation of Myocardial Fatty Acid and Glucose Metabolism in Fasted and Nonfasted Spontaneously Hypertensive Rats Using MicroPET/CT.
Huber JS, Hernandez AM, Janabi M, O'Neil JP, Brennan KM, Murphy ST, Seo Y, Gullberg GT. Huber JS, et al. Mol Imaging. 2017 Jan-Dec;16:1536012117724558. doi: 10.1177/1536012117724558. Mol Imaging. 2017. PMID: 28877656 Free PMC article. - Mitochondria in heart failure.
Rosca MG, Hoppel CL. Rosca MG, et al. Cardiovasc Res. 2010 Oct 1;88(1):40-50. doi: 10.1093/cvr/cvq240. Epub 2010 Jul 28. Cardiovasc Res. 2010. PMID: 20668004 Free PMC article. Review. - Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.
Abel ED, Doenst T. Abel ED, et al. Cardiovasc Res. 2011 May 1;90(2):234-42. doi: 10.1093/cvr/cvr015. Epub 2011 Jan 21. Cardiovasc Res. 2011. PMID: 21257612 Free PMC article. Review. - Metabolomic Profiling Reveals That Exercise Lowers Biomarkers of Cardiac Dysfunction in Rats with Type 2 Diabetes.
Wang T, Ning M, Mo Y, Tian X, Fu Y, Laher I, Li S. Wang T, et al. Antioxidants (Basel). 2024 Sep 26;13(10):1167. doi: 10.3390/antiox13101167. Antioxidants (Basel). 2024. PMID: 39456421 Free PMC article. - FunnyBase: a systems level functional annotation of Fundulus ESTs for the analysis of gene expression.
Paschall JE, Oleksiak MF, VanWye JD, Roach JL, Whitehead JA, Wyckoff GJ, Kolell KJ, Crawford DL. Paschall JE, et al. BMC Genomics. 2004 Dec 20;5(1):96. doi: 10.1186/1471-2164-5-96. BMC Genomics. 2004. PMID: 15610557 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical